WILLIAM KLUGE: Open Payments
NPI 1811420755 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 21 payments from 8 companies in 2025. Trend: 2023 $251 · 2024 $510 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $184 |
| GENZYME CORPORATION | 2 | $143 |
| GlaxoSmithKline, LLC. | 8 | $137 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Regeneron Pharmaceuticals, Inc. | 1 | $120 |
| AERIN MEDICAL INC. | 2 | $51 |
| Amgen Inc. | 1 | $18 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, VOQUEZNA, VIVAER STYLUS.
Industry payments across AZ — which companies pay providers there.
